Medpace (NASDAQ: MEDP) officer to sell 3,400 shares of stock

Rhea-AI Filing Summary

Medpace Holdings, Inc. (MEDP) received a notice under Rule 144 indicating that officer Kevin M. Brady plans to sell up to 3,400 shares of common stock. The planned sale has an aggregate market value of $2,125,816.00, with Medpace reporting 27,911,655 shares outstanding and NASDAQ as the intended trading market.

Key Figures

Shares to be sold: 3,400 shares Aggregate market value: $2,125,816.00 Shares outstanding: 27,911,655 shares +2 more

5 metrics

Shares to be sold 3,400 shares Common stock proposed for sale under Rule 144

Aggregate market value $2,125,816.00 Aggregate market value of the 3,400 shares to be sold

Shares outstanding 27,911,655 shares Common shares outstanding of Medpace Holdings, Inc.

Approximate sale date 08/20/2026 Approximate date of sale for the proposed Rule 144 transaction

Security type Common stock Class of securities covered by the planned Rule 144 sale

Key Terms

Rule 144, stock option exercise, aggregate market value, shares outstanding

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

stock option exercise financial

"Common | 08/20/2026 | Stock Option Exercise | Issuer"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

aggregate market value financial

"Common | Fidelity Brokerage Services LLC ... | 3400 | 2125816.00"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

shares outstanding financial

"| 3400 | 2125816.00 | 27911655 | 08/20/2026 | NASDAQ"

Shares outstanding are the total number of a company’s stock units held by all shareholders, including institutional investors and company insiders — think of them as the total number of slices of the company’s ownership pie. Investors use this number to calculate how much of the company each share represents, and it directly affects per-share measures like earnings per share, ownership percentage and valuation; when the slice count changes, an investor’s claim and the company’s per-share metrics change too.

FAQ

What does the Form 144 filing disclose for Medpace Holdings, Inc. (MEDP)?

The filing discloses that officer Kevin M. Brady intends to sell up to 3,400 MEDP common shares under Rule 144, through Fidelity Brokerage Services LLC, with an aggregate market value of $2,125,816.00 as indicated in the notice.

How many Medpace (MEDP) shares are planned to be sold under this Rule 144 notice?

The notice states a planned sale of 3,400 shares of Medpace common stock. These shares are to be sold through Fidelity Brokerage Services LLC and are associated with a stock option exercise as the stated method of acquisition.

What aggregate market value is associated with the planned Medpace (MEDP) share sale?

The Form 144 lists an aggregate market value of $2,125,816.00 for the 3,400 MEDP shares to be sold. This figure reflects the total market value used for disclosure purposes in connection with the proposed Rule 144 transaction.

How many Medpace (MEDP) shares are reported outstanding in the Form 144?

The notice reports 27,911,655 shares outstanding of Medpace common stock. This number provides context for the planned sale of 3,400 shares, indicating the transaction is small relative to the total shares outstanding.

On which market are the Medpace (MEDP) shares expected to be sold under this notice?

The filing identifies NASDAQ as the market for the proposed sale of Medpace common shares. The approximate date of sale is listed as 08/20/2026, subject to Rule 144 conditions and the filer’s execution decisions.

How will the Medpace (MEDP) shares to be sold under Form 144 be acquired?

The document states the shares are linked to a stock option exercise by Kevin M. Brady. The issuer is listed as the source of the options, with the planned sale date of 08/20/2026 and consideration described as cash.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/20/2026 - 03:20 PM Accepted by SEC EDGAR 08/20/2026 - 03:19 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001877121
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Medpace Holdings, Inc.
SEC File Number	001-37856
Address of Issuer	5375 MEDPACE WAY CINCINNATI OHIO 45227
Phone	(513) 579-9911
Name of Person for Whose Account the Securities are To Be Sold	Brady Kevin M.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	3400	2125816.00	27911655	08/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/20/2026	Stock Option Exercise	Issuer			3400	08/20/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	08/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Adam Gehring, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Kevin Brady
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)